DRITA Pilot Trial: Dietary Reporting in the Amyloidoses
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Adherence Rate
研究概览
简要总结
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis.
The main question it aims to answer is:
Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients
Participants will be asked to:
- Download the MyFitnessPal application on their smartphone and view an online tutorial
- After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone.
- complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age or older
- •Diagnosed with any type of amyloidosis
- •Speak, read and write in English
- •Willing to use the MyFitnessPal app on their own smartphone
排除标准
- •a planned autologous stem cell transplant or a solid organ transplant in the 12 weeks after enrollment
- •cognitive or perceptual disturbances
研究组 & 干预措施
Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
MyFitnessPal smartphone application is used to track daily dietary intake and herbal/alternative supplements.
干预措施: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) (Other)
结局指标
主要结局
Adherence Rate
时间窗: 56 days
The adherence is defined by the status (yes vs. no) of data recording per day; The adherence rate will be calculated by the ratio of the number of days of adherence to the total number of days of trial (i.e., 56 days); The status of data recording per day will be considered 'yes' if the participant completes a daily survey.
次要结局
- Subsequent adherence rate(63 days (= 56 days + Week 10))
研究者
Jeffrey Zonder
Principal Investigator, Multiple Myeloma Multidisciplinary team leader, M.D.
Barbara Ann Karmanos Cancer Institute
